J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.BO)
INR 1574.45
(2.13%)
INR 1574.45
(2.13%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 34.84 Billion INR | 10.63% |
| 2022 | 31.49 Billion INR | 29.91% |
| 2021 | 24.24 Billion INR | 18.69% |
| 2020 | 20.42 Billion INR | 17.2% |
| 2019 | 17.42 Billion INR | 8.23% |
| 2018 | 16.1 Billion INR | 16.36% |
| 2017 | 13.83 Billion INR | 5.6% |
| 2016 | 13.1 Billion INR | 12.17% |
| 2015 | 11.68 Billion INR | 11.39% |
| 2014 | 10.48 Billion INR | 11.73% |
| 2013 | 9.38 Billion INR | 19.44% |
| 2012 | 7.85 Billion INR | 8.92% |
| 2011 | 7.21 Billion INR | -19.0% |
| 2010 | 8.9 Billion INR | 23.28% |
| 2009 | 7.22 Billion INR | 0.76% |
| 2008 | 7.17 Billion INR | 27.5% |
| 2007 | 5.62 Billion INR | 7.01% |
| 2006 | 5.25 Billion INR | 12.86% |
| 2005 | 4.65 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 10.04 Billion INR | 16.56% |
| 2023 Q2 | 8.81 Billion INR | -1.61% |
| 2023 FY | 34.84 Billion INR | 10.63% |
| 2023 Q4 | 8.61 Billion INR | 2.04% |
| 2023 Q3 | 8.44 Billion INR | -4.22% |
| 2023 Q1 | 8.96 Billion INR | 17.56% |
| 2022 Q4 | 7.62 Billion INR | -3.83% |
| 2022 Q1 | 7.84 Billion INR | 25.65% |
| 2022 FY | 31.49 Billion INR | 29.91% |
| 2022 Q2 | 8.09 Billion INR | 3.14% |
| 2022 Q3 | 7.92 Billion INR | -2.07% |
| 2021 Q1 | 6.05 Billion INR | 23.22% |
| 2021 Q4 | 6.24 Billion INR | 3.99% |
| 2021 FY | 24.24 Billion INR | 18.69% |
| 2021 Q3 | 6 Billion INR | 1.29% |
| 2021 Q2 | 5.93 Billion INR | -2.14% |
| 2020 Q1 | 5.22 Billion INR | 26.91% |
| 2020 FY | 20.42 Billion INR | 17.2% |
| 2020 Q4 | 4.91 Billion INR | -10.29% |
| 2020 Q2 | 4.43 Billion INR | -15.07% |
| 2020 Q3 | 5.48 Billion INR | 23.59% |
| 2019 Q3 | 4.28 Billion INR | -6.09% |
| 2019 Q4 | 4.11 Billion INR | -3.99% |
| 2019 Q2 | 4.56 Billion INR | 2.31% |
| 2019 Q1 | 4.46 Billion INR | 15.59% |
| 2019 FY | 17.42 Billion INR | 8.23% |
| 2018 Q1 | 4.06 Billion INR | 0.0% |
| 2018 Q3 | 3.82 Billion INR | -12.25% |
| 2018 FY | 16.1 Billion INR | 16.36% |
| 2018 Q4 | 3.85 Billion INR | 1.03% |
| 2018 Q2 | 4.35 Billion INR | 6.99% |
| 2017 Q1 | 2.83 Billion INR | -7.32% |
| 2017 FY | 13.83 Billion INR | 5.6% |
| 2016 FY | 13.1 Billion INR | 12.17% |
| 2016 Q4 | 3.06 Billion INR | 0.0% |
| 2015 Q4 | 3.02 Billion INR | 0.0% |
| 2015 FY | 11.68 Billion INR | 11.39% |
| 2014 FY | 10.48 Billion INR | 11.73% |
| 2013 Q1 | 2.29 Billion INR | 0.0% |
| 2013 FY | 9.38 Billion INR | 19.44% |
| 2012 FY | 7.85 Billion INR | 8.92% |
| 2012 Q1 | 1.84 Billion INR | 0.0% |
| 2011 FY | 7.21 Billion INR | -19.0% |
| 2010 FY | 8.9 Billion INR | 23.28% |
| 2009 FY | 7.22 Billion INR | 0.76% |
| 2008 FY | 7.17 Billion INR | 27.5% |
| 2007 FY | 5.62 Billion INR | 7.01% |
| 2006 FY | 5.25 Billion INR | 12.86% |
| 2005 FY | 4.65 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 484.96 Billion INR | 92.816% |
| NATCO Pharma Limited | 40.02 Billion INR | 12.939% |
| Suven Pharmaceuticals Limited | 10.51 Billion INR | -231.4% |
| Syncom Formulations (India) Limited | 2.59 Billion INR | -1243.979% |
| Achyut Healthcare Limited | 61.36 Million INR | -56674.329% |
| Ajanta Pharma Limited | 42.08 Billion INR | 17.215% |
| Alkem Laboratories Limited | 126.67 Billion INR | 72.495% |
| Alpa Laboratories Limited | 1.08 Billion INR | -3104.171% |
| Alembic Pharmaceuticals Limited | 61.12 Billion INR | 42.995% |
| AstraZeneca Pharma India Limited | 12.95 Billion INR | -168.939% |
| Aurobindo Pharma Limited | 287.04 Billion INR | 87.862% |
| Bajaj HealthCare Limited | 4.73 Billion INR | -635.964% |
| Bliss GVS Pharma Limited | 7.7 Billion INR | -352.348% |
| Brooks Laboratories Limited | 794.86 Million INR | -4283.388% |
| Divi's Laboratories Limited | 78.45 Billion INR | 55.587% |
| Dr. Reddy's Laboratories Limited | 279.16 Billion INR | 87.519% |
| Eris Lifesciences Limited | 20.09 Billion INR | -73.416% |
| FDC Limited | 19.42 Billion INR | -79.325% |
| Glenmark Pharmaceuticals Limited | 118.13 Billion INR | 70.506% |
| Glenmark Life Sciences Limited | 22.83 Billion INR | -52.6% |
| Granules India Limited | 45.06 Billion INR | 22.683% |
| Gufic Biosciences Limited | 8.06 Billion INR | -331.924% |
| Hester Biosciences Limited | 3.04 Billion INR | -1044.058% |
| Indoco Remedies Limited | 17.89 Billion INR | -94.707% |
| Ind-Swift Laboratories Limited | 12.8 Billion INR | -172.011% |
| Ipca Laboratories Limited | 76.22 Billion INR | 54.29% |
| Jagsonpal Pharmaceuticals Limited | 2.08 Billion INR | -1569.454% |
| Krebs Biochemicals & Industries Limited | 504.21 Million INR | -6810.115% |
| Lasa Supergenerics Limited | 1.04 Billion INR | -3239.42% |
| Laurus Labs Limited | 50.01 Billion INR | 30.341% |
| Lupin Limited | 200.1 Billion INR | 82.589% |
| Mankind Pharma Limited | 103.34 Billion INR | 66.287% |
| Medicamen Biotech Limited | 1.79 Billion INR | -1843.147% |
| Medico Remedies Limited | 1.44 Billion INR | -2304.2% |
| Megasoft Limited | 373.95 Million INR | -9217.17% |
| Piramal Pharma Limited | 81.71 Billion INR | 57.36% |
| RPG Life Sciences Limited | 5.82 Billion INR | -498.606% |
| Sigachi Industries Limited | 3.98 Billion INR | -773.325% |
| Sun Pharma Advanced Research Company Limited | 755.45 Million INR | -4512.046% |
| Unichem Laboratories Limited | 16.57 Billion INR | -110.218% |
| Wanbury Limited | 5.75 Billion INR | -505.261% |
| Windlas Biotech Limited | 6.3 Billion INR | -452.207% |
| ZIM Laboratories Limited | 3.67 Billion INR | -848.272% |
| Zydus Lifesciences Limited | 190.21 Billion INR | 81.683% |
| Procter & Gamble Health Limited | 11.51 Billion INR | -202.641% |
| Amrutanjan Health Care Limited | 4.21 Billion INR | -727.144% |
| Bal Pharma Limited | 3.39 Billion INR | -927.117% |
| Strides Pharma Science Limited | 40.51 Billion INR | 13.995% |
| Venus Remedies Limited | 5.91 Billion INR | -489.092% |
| Aarti Pharmalabs Limited | 18.15 Billion INR | -91.913% |
| Nectar Lifesciences Limited | 16.84 Billion INR | -106.889% |
| Shilpa Medicare Limited | 11.51 Billion INR | -202.551% |
| Aarti Drugs Limited | 25.28 Billion INR | -37.792% |
| IOL Chemicals and Pharmaceuticals Limited | 21.18 Billion INR | -64.429% |
| Suven Life Sciences Limited | 116.92 Million INR | -29697.431% |
| Ind-Swift Limited | 5.02 Billion INR | -593.414% |
| Valiant Laboratories Limited | 1.82 Billion INR | -1813.785% |
| Solara Active Pharma Sciences Limited | 12.38 Billion INR | -181.348% |
| Themis Medicare Limited | 3.81 Billion INR | -812.661% |
| Hikal Limited | 17.84 Billion INR | -95.236% |
| Torrent Pharmaceuticals Limited | 106.05 Billion INR | 67.147% |
| Sequent Scientific Limited | 13.69 Billion INR | -154.37% |
| Novartis India Limited | 3.35 Billion INR | -939.838% |
| Wockhardt Limited | 27.89 Billion INR | -24.926% |
| Jubilant Pharmova Limited | 67.02 Billion INR | 48.02% |
| Biofil Chemicals and Pharmaceuticals Limited | 400.35 Million INR | -8602.779% |
| Neuland Laboratories Limited | 15.58 Billion INR | -123.549% |
| Morepen Laboratories Limited | 17.01 Billion INR | -104.723% |
| Kilitch Drugs (India) Limited | 1.54 Billion INR | -2156.998% |
| Mangalam Drugs & Organics Limited | 3.68 Billion INR | -845.261% |